EFFECT OF ALDOSE REDUCTASE INHIBITION ON GLUTATHIONE REDOX STATUS IN ERYTHROCYTES OF DIABETIC-PATIENTS

被引:41
作者
DEMATTIA, G [1 ]
LAURENTI, O [1 ]
BRAVI, C [1 ]
GHISELLI, A [1 ]
LULIANO, L [1 ]
BALSANO, F [1 ]
机构
[1] NATL INST NUTR,ROME,ITALY
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1994年 / 43卷 / 08期
关键词
D O I
10.1016/0026-0495(94)90175-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic patients undergo a chronic oxidative stress. This phenomenon is demonstrated by low levels of reduced glutathione (GSH) levels. The NADPH used by glutathione reductase for the reduction of oxidized glutathione (GSSG) to GSH is also used by aldose reductase for the reduction of glucose to sorbitol through the polyol pathway. The competition for NADPH could be responsible for the decreased glutathione levels found in non-insulin-dependent diabetic patients. For this purpose, we investigated the effect of polyol pathway inhibition on the glutathione redox status in these patients. We measured GSH and GSSG levels in erythrocytes of non-insulin-dependent diabetic patients (n = 15) before and after 1 week of treatment with placebo, followed by 1 week of treatment with an aldose reductase inhibitor (tolrestat 200 mg/d). We found lower GSH levels (7.7 ± 1.4 μmol/g hemoglobin [Hb]), higher GSSG levels (0.35 ± 0.09 μmol/g Hb), and lower GSH/GSSG ratios (23.9 ± 7.7) in diabetics compared with controls (n = 15; 9.8 ± 0.8 μmol/g Hb, P < .001; 0.17 ± 0.02, P < .001; and 58.3 ± 9.1, P < .001, respectively). We did not demonstrate any statistical difference after 1 week of treatment with placebo. In contrast, the treatment with tolrestat induced a significant increase in GSH (8.9 ± 0.7 μmol/g Hb, P < .01), a decrease in GSSG (0.25 ± 0.06 μmol/g Hb, P < .02), and an increase in the GSH/GSSG ratio (37.3 ± 8.4, P < .01). These data strongly support the hypothesis that the polyol pathway plays an important role in the impairment of the glutathione redox status in diabetic patients. © 1994.
引用
收藏
页码:965 / 968
页数:4
相关论文
共 29 条
[1]  
ANDREOLI SP, 1986, J LAB CLIN MED, V108, P190
[2]   THE EFFECT OF OXIDATION ON SORBITOL PATHWAY KINETICS [J].
BARNETT, PA ;
GONZALEZ, RG ;
CHYLACK, LT ;
CHENG, HM .
DIABETES, 1986, 35 (04) :426-432
[3]   NONENZYMATIC GLYCOSYLATION AND THE PATHOGENESIS OF DIABETIC COMPLICATIONS [J].
BROWNLEE, M ;
VLASSARA, H ;
CERAMI, A .
ANNALS OF INTERNAL MEDICINE, 1984, 101 (04) :527-537
[4]  
BROWNLEE M, 1987, DIABETIC COMPLICATIO, P94
[5]   GLYCOSYLATION OF HEMOGLOBIN - RELEVANCE TO DIABETES-MELLITUS [J].
BUNN, HF ;
GABBAY, KH ;
GALLOP, PM .
SCIENCE, 1978, 200 (4337) :21-27
[6]  
CASINI AF, 1988, FREE RADICAL METHODO, P515
[7]  
CHOW CK, 1991, FREE RADICAL BIO MED, V11, P215
[8]   FREE-RADICAL ACTIVITY IN TYPE-2 DIABETES [J].
COLLIER, A ;
WILSON, R ;
BRADLEY, H ;
THOMSON, JA ;
SMALL, M .
DIABETIC MEDICINE, 1990, 7 (01) :27-30
[9]  
DAIMANT E, 1955, J BIOL CHEM, V213, P769
[10]  
DIMANT E, 1955, J BIOL CHEM, V213, P769